Telma: Building and Defending a Market Leader Case Solution And Analysis, HBR Case Study Solution & Analysis of Harvard Case Studies

This case follows the inception to the rise of Telma, the flagship brand of Glenmark Pharmaceuticals, over its decade of existence. Telma based on the molecular formula Telmisartan was introduced by Glenmark in 2003 at a time when the most preferred and market-top molecule for treating hypertension was Ramipril. This case, not only showcases the brand-building plans undertaken by Glenmark through the life of Telma, but in addition traces the marketing efforts that go into creating a new class that will subsequently go on to become the market leader. The case also introduces students to the evolving regulatory framework which has shaped pharmaceutical marketing practices of generics makers in India since independence.

Telma Building and Defending a Market Leader case study solution

This is just an excerpt. This case is about SALES & MARKETING

PUBLICATION DATE: July 21, 2015 PRODUCT #: IMB521-PDF-ENG